QUALZICE: A QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates

Trials

Volumn 14, Issue 1, 2013, Pages

  Nelson, Annmarie ^a   Fenlon, Debbie ^b   Morris, Jenny ^c   Sampson, Cathy ^a   Harrop, Emily ^a   Murray, Nick ^d   Wheatley, Duncan ^e   Hood, Kerenza ^a   Griffiths, Gareth ^a   Barrett Lee, Peter ^f  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF PLYMOUTH   (United Kingdom)

^d Calvary North Adelaide Hospital   (Australia)

^e ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^f VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Bisphosphonates; Breast cancer; Clinical trial; Patient experience; Qualitative

Indexed keywords

ANASTROZOLE; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; TRASTUZUMAB; ZOLEDRONIC ACID;

ARTICLE; BREAST METASTASIS; CANCER FATIGUE; CANCER PAIN; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FLU LIKE SYNDROME; HEALTH CARE ACCESS; HUMAN; INDIGESTION; NAUSEA; PERSONAL EXPERIENCE; POLYPHARMACY; QUALITATIVE RESEARCH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEMI STRUCTURED INTERVIEW;

ADMINISTRATION, ORAL; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; COMPREHENSION; DIPHOSPHONATES; ENGLAND; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; PAIN MEASUREMENT; PATIENT PREFERENCE; PATIENT SATISFACTION; PATIENTS; QUALITATIVE RESEARCH; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME; WALES;

EID: 84885038804     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-325     Document Type: Article

References (18)

1. Jansen Y, Foets M, de Bont A. The contribution of qualitative research to the development of tailor-made community-based interventions in primary care: a review. Eur J Public Health 2009, 20(2):220-226.
2. Oakley A, Strange V, Bonell C, Allen E. RIPPLE Study Team: Process evaluation in randomised controlled trials of complex interventions. Br Med J 2006, 332(7538):413-416.
3. Paterson C, Baarts C, Launso L, Verhoef M. Evaluating complex health interventions: a critical analysis of the 'outcomes' concept. BMC Complement Altern Med 2009, 9:18. 10.1186/1472-6882-9-18, 2712450, 19538715.
4. Abbey S, De Luca E, Mauthner O, McKeever P, Shildrick M, Poole J, Gewarges M, Ross H. Qualitative interviews vs standardized self-report questionnaires in assessing quality of life in heart transplant recipients. J Heart Lung Transplant 2011, 30(8):963-966.
5. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, Frankel S, Neal D, Hamdy F. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Br Med J 2002, 325(7367):766-770.
6. Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan J. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial. Trials 2011, 12:78. 10.1186/1745-6215-12-78, 3068963, 21406089.
7. Smith J, Flowers P, Larkin M. Interpretative Phenomenological Analysis: Theory, Method, Research 2009, London: Sage.
8. Smith JA, Osborn M. Interpretative phenomenological analysis. Qualitative Psychology: A Practical Guide to Research Methods 2003, 51-80. London: Sage: Smith J.
9. Smith J. Qualitative Psychology: A Practical Guide to Research Methods 2008, London: Sage, 2.
10. Chapman E, Smith J. Interpretative phenomenological analysis and the new genetics. J Health Psychol 2002, 7(2):125-130. 10.1177/1359105302007002397, 22114232.
11. Miller F, Rosenstein D. The therapeutic orientation to clinical trials. New Eng Med J 2003, 348(14):1383-1386.
12. Sulmasy D, Astrow A, He M, Seils D, Meropol N, Micco E, Weinfurt K. The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer 2010, 116(15):3702-3711. 10.1002/cncr.25201, 3644988, 20564120.
13. Henderson G, Churchill L, Davis A, Easter M, Grady C, Joffe S, Kass N, King N, Lidz C, Miller F, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med 2007, 4(11):e324. 10.1371/journal.pmed.0040324, 2082641, 18044980.
14. Appelbaum P, Lidz C. Twenty-five years of therapeutic misconception. Hastings. Cent Rep 2008, 38(2):5-6. Author reply 6-7.
15. Fallowfield L, Ford S, Lewis S. No news is not good news: information preferences of patients with cancer. Psycho-Oncology 1995, 4(3):197-202. 10.1002/pon.2960040305, 11655006.
16. Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001, 84(1):48-51. 10.1054/bjoc.2000.1573, 2363610, 11139312.
17. Leydon G, Boulton M, Moynihan C, Jones A, Mossman J, Boudioni M, McPherson K. Cancer patients' information needs and information seeking behaviour: in depth interview study. Br Med J 2000, 320(7239):909-913.
18. Pinder R. The Management of Chronic Illness 1990, London: Macmillan.